These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 14153094)

  • 1. [ELIMINATION OF THE PRINCIPAL URINARY METABOLITES OF SEROTONIN, DOPAMINE, NORADRENALINE, AND ADRENALINE DURING TREATMENT WITH RESERPINE AND WITH CHLOROPROMAZINE IN SCHIZOPHRENIC SUBJECTS. CLINICO-BIOLOGICAL CORRELATIONS].
    BRUNO A; BOZZI R; ALLEGRANZA A; DEVITO C
    Riv Patol Nerv Ment; 1963 Sep; 84():451-92. PubMed ID: 14153094
    [No Abstract]   [Full Text] [Related]  

  • 2. [URINARY ELIMINATION OF 5-HYDROXYINDOLACETIC ACID, HOMOVANILLIC AND VANILLYLMANDELIC ACIDS IN SCHIZOPHRENIC SUBJECTS WITH RESERPINE AND CHLORPROMAZINE].
    ALLEGRANZA A; BOZZI R; BRUNO A
    Riv Patol Nerv Ment; 1963 Jun; 84():181-200. PubMed ID: 14088041
    [No Abstract]   [Full Text] [Related]  

  • 3. URINARY METABOLITES OF SOME MONOAMINES AND CLINICAL EFFECTS UNDER RESERPINE AND CHLORPROMAZINE.
    BOZZI R; BRUNO A; ALLEGRANZA A
    Br J Psychiatry; 1965 Feb; 111():176-82. PubMed ID: 14270530
    [No Abstract]   [Full Text] [Related]  

  • 4. ETHANOL AND URINARY CATECHOLAMINES IN MAN.
    ANTON AH
    Clin Pharmacol Ther; 1965; 6():462-9. PubMed ID: 14314969
    [No Abstract]   [Full Text] [Related]  

  • 5. THE EFFECT OF RESERPINE, CHLORPROMAZINE AND HALOPERIDOL ON THE MONOAMINES IN CENTRAL NERVOUS SYSTEM.
    Roos BE
    Acta Psychiatr Scand; 1964; 39(S180):421-2. PubMed ID: 14345228
    [No Abstract]   [Full Text] [Related]  

  • 6. [URINARY ELIMINATION OF VANYLMANDELIC ACID AND 5-HYDROXY-INDOLACETIC ACID DURING PREGNANCY IN A SUBJECT OPERATED ON FOR PHEOCHROMOCYTOMA].
    BATTAGLIA GB
    Riv Ostet Ginecol; 1964 Jun; 19():346-52. PubMed ID: 14178269
    [No Abstract]   [Full Text] [Related]  

  • 7. The urinary excretion of adrenaline and noradrenaline by schizophrenic patients during reserpine treatment.
    CARLSSON A; RASMUSSEN EB; KRIST JANSEN P
    J Neurochem; 1959 Oct; 4():318-20. PubMed ID: 13807780
    [No Abstract]   [Full Text] [Related]  

  • 8. UPTAKE AND RELEASE OF DEXTRO- AND LAEVO-ADRENALINE IN NORADRENERGIC STORES.
    ANDEN NE
    Acta Pharmacol Toxicol (Copenh); 1964; 21():59-75. PubMed ID: 14173463
    [No Abstract]   [Full Text] [Related]  

  • 9. EFFECT OF DRUGS ON THE LEVELS OF INDOLE AND PHENOLIC ACIDS IN THE CENTRAL NERVOUS SYSTEM.
    ROOS BE; ANDEN NE; WERDINIUS B
    Int J Neuropharmacol; 1964 Apr; 3():117-22. PubMed ID: 14334586
    [No Abstract]   [Full Text] [Related]  

  • 10. [3-METHOXY-4-HYDROXY-BENZALDEHYDE (VANILLIN) AS A METABOLITE OF ADRENALINE AND NORADRENALINE].
    THOMAS H; DIRSCHERL W
    Acta Endocrinol (Copenh); 1964 Sep; 47():69-75. PubMed ID: 14205295
    [No Abstract]   [Full Text] [Related]  

  • 11. RESERPINE TOLERANCE TEST IN SCHIZOPHRENIC SUBJECTS.
    BRUNO A; ALLERGRANZA A; BOZZI R
    J Nerv Ment Dis; 1964 Sep; 139():241-6. PubMed ID: 14212176
    [No Abstract]   [Full Text] [Related]  

  • 12. EXCRETION OF DOPAMINE, CATECHOLAMINE METABOLITES AND 5-HYDROXYINDOLEACETIC ACID IN HEPATOLENTICULAR DEGENERATION (WILSON'S DISEASE).
    SOURKES TL; MURPHY GF; SANKOFF I; WISEMAN-DISTLER MH; SAINTCYR S
    J Neurochem; 1963 Dec; 10():947-51. PubMed ID: 14090776
    [No Abstract]   [Full Text] [Related]  

  • 13. EFFECT OF RESERPINE AND GUANETHEDINE ON EXCRETION OF 3-METHOXY-4-HYDROXYMANDELIC ACID IN MAN.
    WOODS JW; AJZEN H
    Proc Soc Exp Biol Med; 1963 Oct; 114():107-9. PubMed ID: 14076851
    [No Abstract]   [Full Text] [Related]  

  • 14. EXCRETION OF CATECHOLAMINES AND EXACERBATION OF SYMPTOMS IN SCHIZOPHRENIC PATIENTS.
    PSCHEIDT GR; BERLET HH; BULL C; SPAIDE J; HIMWICH HE
    J Psychiatr Res; 1964 Oct; 2():163-8. PubMed ID: 14242374
    [No Abstract]   [Full Text] [Related]  

  • 15. [5-Hydroxyindoleacetic acid excretion in urine of schizophrenics with reference to effects of chlorpromazine and reserpine on serotonin metabolism].
    SANO I; KAKIMOTO Y; OKAMOTO T; NAKAJIMA H; KUDO Y
    Schweiz Med Wochenschr; 1957 Mar; 87(9):214-7. PubMed ID: 13432651
    [No Abstract]   [Full Text] [Related]  

  • 16. The effect of reserpine on catecholamine metabolism and behavior in retarded children.
    Anton AH
    Clin Pharmacol Ther; 1966; 7(6):727-39. PubMed ID: 5918009
    [No Abstract]   [Full Text] [Related]  

  • 17. URINARY CATECHOL AMINES AND THEIR METABOLITES IN HYPERTHYROIDISM AND HYPOTHYROIDISM.
    WISWELL JG; HURWITZ GE; CORONHO V; BING OH; CHILD DL
    J Clin Endocrinol Metab; 1963 Nov; 23():1102-6. PubMed ID: 14084128
    [No Abstract]   [Full Text] [Related]  

  • 18. [STUDIES OF THE URINARY 5-HYDROXYINDOLEACETIC ACID WITH SPECIAL REFERENCE TO CASES WITH THYROID DISORDERS].
    CHIBA N
    Tohoku Igaku Zasshi; 1963 May; 67():543-61. PubMed ID: 14159772
    [No Abstract]   [Full Text] [Related]  

  • 19. URINARY EXCRETION OF CATECHOL AMINES IN THE RAT AFTER THEIR LIBERATION BY RESERPINE OR DEXAMPHETAMINE.
    BISCARDI AM; CARPI A; ORSINGHER OA
    Br J Pharmacol Chemother; 1964 Dec; 23(3):529-39. PubMed ID: 14256812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [URINARY ELIMINATION OF 5-HYDROXYINDOLACETIC ACID AND 3-METHOXY-4-HYDROXY-MANDELIC ACID AFTER INTRAMUSCULAR ADMINISTRATION OF SEROTONIN IN WOMEN DURING NORMAL AND PATHOLOGICAL PREGNANCY].
    PERITI P; GASPARRI F; BATTAGLIA GB; SANTINI D
    Boll Soc Ital Biol Sper; 1963 Dec; 39():1647-51. PubMed ID: 14129422
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.